Foreign body granulomas after all injectable dermal fillers: Part 2. treatment options

Plastic and Reconstructive Surgery

Volumn 123, Issue 6, 2009, Pages 1864-1873

  Lemperle, Gottfried ^a,b   Gauthier Hazan, Nelly ^a,b  

^a University of California ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA2B INTERFERON; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BLEOMYCIN; COLLAGEN; COLLAGEN IMPLANT; CORTICOSTEROID; DERMAL FILLER; DEXAMETHASONE; DEXTRAN; FILLER; FLUOROURACIL; HYALURONIC ACID DERIVATIVE; HYDROXYAPATITE; IBUPROFEN; IMIQUIMOD; ISOTRETINOIN; LIQUID PARAFFIN; METHYLCELLULOSE; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE; MICROSPHERE; MINOCYCLINE; PARAFFIN; POLY(METHYL METHACRYLATE); POLYACRYLAMIDE GEL; POLYLACTIC ACID; POLYMACON; PREDNISOLONE; PREDNISONE; SILICONE OIL; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC ANTIMETABOLITE; LIDOCAINE; LOCAL ANESTHETIC AGENT;

CELL INFILTRATION; CLINICAL FEATURE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CYSTIC GRANULOMA; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; EDEMATOUS GRANULOMA; FOREIGN BODY GRANULOMA; GRANULATION TISSUE; HISTOPATHOLOGY; HUMAN; IMPLANTATION; INJECTION SITE; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MULTIPLE CYCLE TREATMENT; NONHUMAN; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SCLEROSING GRANULOMA; SKIN ATROPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; CASE REPORT; DERMIS; DRUG COMBINATION; FEMALE; INJECTION;

ANESTHETICS, LOCAL; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; BETAMETHASONE; DERMIS; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; GRANULOMA, FOREIGN-BODY; HUMANS; INJECTIONS; LIDOCAINE; METHYLPREDNISOLONE; MINOCYCLINE; TRIAMCINOLONE;

EID: 67649388244     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181858f4f     Document Type: Review

References (76)

1. Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: Part 1. Possible causes. Plast Reconstr Surg. 2008;123:1864-1873.
2. Khoo Boo-Chai MB. Paraffinoma. Plast Reconstr Surg. 1965; 36:101.
3. Duffy DM. Liquid silicone for soft tissue augmentation: Histological, clinical, and molecular perspectives. Dermatol Surg. 2007;31:1530.
4. Maas CS, Papel ID, Greene D, et al. Complications of injectable synthetic polymers in facial augmentation. Dermatol Surg. 1997;23:871.
5. Ficarra G, Mosqueda-Taylor A, Carlos R. Silicone granuloma of the facial tissue: A report of seven cases. Oral Surg Oral Med Oral Pathol 2002;94:65.
6. Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft-tissue augmentation. Plast Reconstr Surg. 1977;60:398.
7. Moscona RR, Bergman R, Friedman-Birnbaum R. An unusual late reaction to Zyderm I injections: A challenge for treatment. Plast Reconstr Surg. 1993;92:331.
8. Ersek RA. More on Bioplastique. Aesthet Plast Surg. 2000; 24:461.
9. Lemperle G, Pietz R, Lemperle M. First clinical experiences with Arteplast (polymethyl-methacrylate microspheres) injected beneath wrinkles and dermal defects. In: Hinderer UT, ed. Plastic Surgery 1992, Vol. II. Amsterdam: Elsevier Science Publishers B.V.; 1992:539-541.
10. Lemperle G, Holmes R, Larson FG. Reply on Dr. Kessel's Commentary. Aesthet Plast Surg. 2000;24:74.
11. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29:573.
12. Borges Fortes F, Lemperle G, Charrier U. Electron microscopy and human histology of different dermal fillers containing PMMA-microspheres. Rev Soc Brasil Cir Plast. (in press).
13. Salles AG, Lotierzo PH, Gemperli R, et al. Complications after polymethylmethacrylate injections: Report of 32 cases. Plast Reconstr Surg. 2008;121:1811.
14. Bergeret-GalleyC,LatoucheX,Illouz Y-G. The value ofa new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthet Plast Surg. 2001;25:249.
15. Laglenne S. Un nouveau produit de comblement des rides, entirement resorbable. Dermatologie 2000;54:30.
16. Lombardi T, Samson J, Plantier F, et al. Orofacial granuloma after injection of cosmetic fillers: Histopathologic and clinical study of 11 cases. J Oral Pathol Med. 2004;33:115.
17. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26: 135.
18. Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000;106:1215.
19. Alijotas-Reig J, Garcia-Giminez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: Clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol. 2008;22:150.
20. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(3 Suppl):22S.
21. Christensen LH, Breiting VB, Aasted A, et al. Long-term effects of polyacrylamide hydrogel on human breast tissue. Plast Reconstr Surg. 2003;111:1883.
22. Mazzoleni F, Dominici C,Lotti T, et al. Formacryl®:Unnuovo biopolimero al servizio della medicina "piu un endoprotesi che un filler." Dermatologia 2000;1:13.
23. De Cassia Novaes W, Berg A. Experience with a new nonbiodegradable hydrogel (Aquamid): A pilot study. Aesthet Plast Surg. 2003;27:376.
24. Casavantes LC, Izabel JM. Estabilidad, tolerancia y seguridad de polialquilimida gel (BioAlcamid™), endoprotesis inyectable para la correction de defectos mayors en tejidos blandos. Dermatologia CMQ. 2004;2:98.
25. Karim RB, Hage JJ, van Rozelaar L, Lange CAH, Raaijmakers J. Complications of polyalkylimide 4% injections (Bio-Alc- amid™): A report of 18 cases. J Plast Reconstr Aesthet Surg. 2006;59:1409.
26. Cheng N-X, Wang Y-L, Zhang X-M, et al. Complications of breast augmentation with injected hydrophilic polyacrylamide gel. Aesthet Plast Surg. 2002;26:375.
27. LemperleG,Morhenn VB, CharrierU.Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg. 2003;27:354.
28. Alkan M, Ciftci AO, Talim B, Senocak ME, Caglar M, Buyukpamukcu N. Histological response to injected dextranomer-based implant in a rat model. Pediatr Surg Int. 2007;23:183.
29. Bedir S, Kilciler M, Oezgoek Y, Deveci G, Erduran D. Long-term complication due to dextranomer based implant: Granuloma causing urinary obstruction. J Urol. 2004;172:247.
30. Castillo-Vico MT, Checa-Vizcaino MA, Paya-Panades A, Rueda-Garcia C, Carreras-Collado R. Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:95.
31. Bigata X, Ribera M, Bielsa I, et al. Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol Surg. 2001;27:198.
32. Duffy DM. Tissue injectable liquid silicone: New perspectives. In: Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and Techniques. 2nd ed. New York: Taylor & Francis; 2005:159.
33. Senet P, Bachelez H, Ollivaud L, et al. Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol. 1999;140:985.
34. Ghislanzoni M, Bianchi F, Barbareschi M, Alessi E. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol. 2006;154:755.
35. André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA, Q-Medical, Sweden) in European countries: A retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18:422.
36. Distante F, Bandiera A, Bellini R, et al. Studio multricentrico italiano sull'efficacia e la, tollerabilita dell'acido ialuronico di origine non animale (Restylane) nel trattamento degli inestetismi del volto. Gio Ital Dermatol Venerol. 2001;136:293.
37. Hoenig JF, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg. 2003;14:197.
38. Apikian M, Roberts S, Goodman GJ. Adverse reactions to polylactic acid injections in the periorbital area. J Cosmet Dermatol. 2007;6:95.
39. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006; 118 (Suppl. 3S):92S.
40. Vargas-Machuca I, Gonzalez-Guerra E, Angulo J, del Carmen FarinaM,MartinL,Requena L.Facial granulomas secondary to Dermalive microimplants: Report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol. 2006;28:173.
41. Angus JE, Affleck AG, Leach IH, Millard LG. Two cases of delayed granulomatous reactions to to the cosmetic filler Dermalive®, a hyaluronic acid and acrylic hydrogel. Br J Dermatol. 2006;155:1077.
42. Reisberger E-M, Landthaler M, Wiest L, et al. Foreign body granulomas caused by polymethylmethacrylate microspheres. Arch Dermatol. 2003;139:17.
43. Lloret P, Espana A, Leache A, et al. Successful treatment of granulomatous reactions secondary to injection of esthetic implants. Dermatol Surg. 2005;31:486.
44. Carroll LA, Hanasono MM, Mikulec AA, et al. Triamcinolone stimulates bFGF production and inhibits TGF-b1 production by human dermal fibroblasts. Dermatol Surg. 2002;28:704.
45. Oishi Y, Fu ZW, Ohnuki Y, et al. Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: Effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases. Br J Dermatol. 2002;147:859.
46. Schoepe S, Schaecke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol. 2006;15:406.
47. Fardet L, Flahault A, Kettaneh A, et al. Corticosteroid-induced clinical adverse events: Frequency, risk factors and patient's opinion. Br J Dermatol. 2007;157:142.
48. Cramer JE. Intra-lesional injection of triamcinolone. Australas J Dermatol. 1964;13:140.
49. Myers E, Shea CR Krausz T, Petronic-Rosic V. Eosinophilic granuloma of the skin: Response to intralesional corticosteroid injection. J Drugs Dermatol. 2007;6:329.
50. Overholt MA, Tschen JA, Font RL. Granulomatous reaction to collagen implant: Light and electron microscopic observations. Cutis 1993;51:95.
51. Morton AH, Shannon P, Chen A, et al. Increased frequency of acute local reaction to intra-articular Hylan G-F 20 (Synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg (Am.) 2003;85:2050.
52. Zardawi IM. Granulomatous inflammation after Hylan G-F 20 visco supplementation of the knee. J Bone Joint Surg (Am.) 2003;85:2484.
53. DeBree R, Middelweerd MJ, van der Waal I. Severe granulomatous inflammatory response induced by injection of polyacrylamide gel into facial tissue. Arch Facial Plast Surg. 2004;6:204.
54. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. AustralasJ Dermatol. 2004;45:140.
55. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg. 2004;114:277.
56. Nuutinen P, Autio P, Hurskainen T, et al. Glucocorticoid action on skin collagen: Overview on clinical significance and consequences. J Eur Acad Dermatol Venerol. 2001;15:361.
57. Espana A, Solana T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27:23.
58. Yosipovitch G, Widijanti SM, Goon A, et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: A controlled study. J Dermatol Treat. 2001;12:87.
59. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006; 32:907.
60. Lee JH, Kim SE, Lee AY. Effects of interferon-a2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol. 2008;47:183.
61. Carruthers A, Carruthers JDA. Polymethylmethacrylate microspheres/ collagen as a tissue augmenting agent: Personal experience over 5 years. Dermatol Surg. 2005;31:1561.
62. Fisher D. Adverse effects of topical corticosteroid use. West J Med. 1995;162:123.
63. Fitzpatrick RE, Manuskiatti W. Laser, steroid, and 5-FU therapy appear comparable for keloid scars. Arch Dermatol. 2002; 138:1149.
64. Conejo-Mir JS, Guirado SS, Munoz MA. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg. 2006; 32:1079.
65. Narins RS, Brandt F, Leyden J, et al. Randomized, doubleblind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588.
66. Saray Y, Guelec T. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: A preliminary study. Int J Dermatol. 2005;44:777.
67. Garcia-Domingo MI, Alijtas-Reig J, Cistero-Bahima A, et al. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. J Invest Allergol Clin Immunol. 2000;10:107.
68. Sanchez Garcia V, Sanz Trelles A. Superficial granulomatous pyoderma: Successful treatment with minocycline. J Eur Acad Dermatol Venerol. 2006;20:1134.
69. Aivaliotis M, Kontochristopoulos G, Hatziolou E, Aroni K, Zakopoulou N. Successful cholcicine administration in facial granulomas caused by cosmetic implants: Report of a case. J Dermatol Treatment 2007;18:112.
70. Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg. 1999;25:247.
71. Jain S, Stephens CJM. Successful treatment of disseminated granulomas annulare with topical tacrolimus. Br J Dermatol. 2004;150:1042.
72. Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC. The natural history of polymethylmethacrylate microspheres granulomas. Dermatol Surg. 2007;33:614.
73. BouzaniN,Davis SC, Nouri K.Laser treatmentof keloids and hypertrophic scars. Int J Dermatol. 2007;46:80.
74. Wolfram D, Tzankov A, Piza-Katzer H. Surgery for foreign body reactions due to injectable fillers. Dermatology 2006; 213:300.
75. El-Shafey El-SI. Complications from repeated injection or puncture of polyacrylamide gel implant sites: Case reports. Aesthetic Plast Surg. 2008;32:162.
76. Soparkar CN, Patrinely JR, Tschen J. Erasing Restylane. Ophthal Plast Reconstr Surg. 2004;20:317.